Tumour necrosis factor in inflammation: relation to other mediators and to macrophage antitumour defence.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Pharmacological Research

• Publication date

  1991-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/1043-6618(91)90027-UPMID 1749743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signalling pathway of tumor necrosis factor in normal and tumor cells

  2004cited by this paper
• Indomethacin stimulation of macrophage cytostasis against MOPC-315 tumor cells is inhibited by both prostaglandin E2 and nordihydroguaiaretic acid, a lipoxygenase inhibitor

  2004cited by this paper
• Prostaglandin E2 enhances, and leukotriene C4 inhibits, interleukin-1 inhibition of WEHI-3B cell growth

  2004cited by this paper
• Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock.

  1991cited by this paper
• Sequential release of eicosanoids during endotoxin-induced shock in anesthetized pigs.

  1991cited by this paper
• Platelet activating factor is one of the mediators involved in endotoxic shock in pigs.

  1991cited by this paper
• Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis.

  1991cited by this paper
• Macrophage cytokines render WEHI-3B tumor cells susceptible to cytostasis by prostaglandins.

  1990cited by this paper
• TNF- and LPS-induced changes of lung vascular permeability: studies in unanesthetised sheep.

  1990cited by this paper
• Adaptation to bacterial lipopolysaccharide controls lipopolysaccharide-induced tumor necrosis factor production in rabbit macrophages.

  1990cited by this paper
• Interactions between inflammatory mediators in expression of antitumor cytostatic activity of macrophages.

  1990cited by this paper
• METABOLISM AND PHARMACOKINETICS OF BIOLOGICAL RESPONSE MODIFIERS (BRMS)

  1990cited by this paper
• [The acute phase reaction and its mediators. II: Alpha tumor necrosis factor and interleukin 6].

  1990cited by this paper
• Antitumor activity of recombinant interleukin 6 in mice

  1990cited by this paper
• Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.

  1990cited by this paper
• Endotoxin‐stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin‐1βin vitro during infectious peritonitis

  1990cited by this paper
• Effect of gram-negative endotoxin on levels of serum corticosterone, TNF alpha, circulating blood cells, and the survival of rats.

  1990cited by this paper
• Lymphokines and cytokines as cancer treatment.Immunotherapy realized

  1990cited by this paper
• Macrophages and cancer

  1990cited by this paper
• Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1

  1990cited by this paper
• Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.

  1990cited by this paper
• Distinct tumor cell membrane constituents activate human monocytes for tumor necrosis factor synthesis.

  1990cited by this paper
• Effects of anti-inflammatory agents on lymphocyte migration stimulated by the interferons, tumor necrosis factor and cutaneous inflammation.

  1989cited by this paper
• In vitro production of IL 1β, IL 1α, TNF and IL 2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation

  1989cited by this paper
• Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo.

  1989cited by this paper
• Oxidative damage in murine tumor cells treated in vitro by recombinant human tumor necrosis factor.

  1989cited by this paper
• Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.

  1989cited by this paper
• Regulation of Monokine Gene Expression: Prostaglandin E2 Suppresses Tumor Necrosis Factor but Not Interleukin‐1α or β‐mRNA and Cell‐Associated Bioactivity

  1989cited by this paper
• In vitro production of IL 1 beta, IL 1 alpha, TNF and IL2 in healthy subjects: distribution, effect of cyclooxygenase inhibition and evidence of independent gene regulation.

  1989cited by this paper
• Tumour necrosis factor production by IL-2-activated macrophages in vitro and in vivo.

  1989cited by this paper
• Regulation of interleukin-1β and tumor necrosis factor secretion by the human monocytic leukemia cell line, THP-1

  1989cited by this paper
• Acute and chronic inflammatory responses to local administration of recombinant IL-1 alpha, IL-beta, TNF alpha, IL-2 and Ifn gamma in mice.

  1989cited by this paper
• Comparative Study of Cytotoxicity, Tumor Necrosis Factor, and Prostaglandin Release After Stimulation of Rat Kupffer Cells, Murine Kupffer Cells, and Murine Inflammatory Liver Macrophages

  1989cited by this paper
• Control by IFN-gamma and PGE2 of TNF alpha and IL-1 production by human monocytes.

  1989cited by this paper
• Regulation of monokine gene expression: prostaglandin E2 suppresses tumor necrosis factor but not interleukin-1 alpha or beta-mRNA and cell-associated bioactivity.

  1989cited by this paper
• Biologic and Immunohistochemical Analysis of Macrophage lnterleukin‐1α, ‐1β, and Tumor Necrosis Factor Production During the Peritoneal Exudative Response

  1989cited by this paper
• Synergism of prostaglandin E2 plus TNF in induction of differentiation of human monocytoid leukemic U-937 cells.

  1989cited by this paper
• Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.

  1989cited by this paper
• Relationship between tumour cell morphology, gap junctions and susceptibility to cytolysis by tumour necrosis factor.

  1989cited by this paper
• A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

  1989cited by this paper
• Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.

  1989cited by this paper
• Cachectin/TNF mediates the pathophysiological effects of bacterial endotoxin/lipopolysaccharide (LPS).

  1988cited by this paper
• Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability.

  1988cited by this paper
• Detection of circulating tumor necrosis factor after endotoxin administration.

  1988cited by this paper
• Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.

  1988cited by this paper
• Destruction of tumor cells by monokines released from activated human blood monocytes: evidence for parallel and additive effects of IL-1 and TNF

  1988cited by this paper
• Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1.

  1988cited by this paper
• Cytostatic product(s) released by activated macrophages, unrelated to interleukin 1, tumor necrosis factor alpha, and interferon-alpha/beta.

  1988cited by this paper
• Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides.

  1988cited by this paper
• Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

  1988cited by this paper
• Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.

  1988cited by this paper
• Cytostatic product(s) released by activated macrophages, unrelated to interleukin 1, tumor necrosis factor α, and interferon-αβ

  1988cited by this paper
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

  1987cited by this paper
• Synergistic anti-proliferative activity of interleukin 1 and tumor necrosis factor.

  1987cited by this paper
• Leukotriene D4 and indomethacin enhance additively the macrophage cytostatic activity in vitro towards MOPC-315 tumour cells.

  1987cited by this paper
• Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.

  1987cited by this paper
• Down regulation of the receptors for tumor necrosis factor by interleukin 1 and 4 beta-phorbol-12-myristate-13-acetate.

  1987cited by this paper
• Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

  1987cited by this paper
• The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors.

  1987cited by this paper
• Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury.

  1987cited by this paper
• Tumor necrosis factor and interleukin-1: role in acute inflammation and microvascular injury.

  1987cited by this paper
• Tumor necrosis factors - TNF-α and TNF-β: Their structure and pleiotropic biological effects

  1987cited by this paper
• Interferon-gamma synergizes with tumor necrosis factor and with interleukin 1 and requires the presence of both monokines to induce antitumor cytotoxic activity in macrophages.

  1987cited by this paper
• Modulation of receptors and cytotoxic response of tumor necrosis factor-alpha by various lectins.

  1986cited by this paper
• Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

  1986cited by this paper
• Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

  1986cited by this paper
• Immunopharmacology of tumor necrosis factors α and β

  1986cited by this paper
• Cytotoxins (tumour necrosis factor, lymphotoxin and others): molecular and functional characteristics and interactions with interferons.

  1986cited by this paper
• Tumor necrosis factor induction by Sendai virus.

  1986cited by this paper
• Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon

  1985cited by this paper
• Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

  1985cited by this paper
• Characterization of receptors for human tumour necrosis factor and their regulation by γ-interferon

  1985cited by this paper
• Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells.

  1985cited by this paper
• Tumor necrosis factor (TNF).

  1985cited by this paper
• Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

  1984cited by this paper
• Immunomodulatory-antiinflammatory functions of E-type prostaglandins. Minireview with emphasis on macrophage-mediated effects.

  1982cited by this paper
• Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.

  1978cited by this paper
• Inflammation: Mechanisms and their Impact on Therapy

  1977cited by this paper
• Histopathology of acute and chronic inflammation.

  1977cited by this paper
• An endotoxin-induced serum factor that causes necrosis of tumors.

  1975cited by this paper
• Action of Bacterial Polysaccharide on Tumors. II. Damage of Sarcoma 37 by Serum of Mice Treated With Serratia Marcescens Polysaccharide, and Induced Tolerance

  1962cited by this paper
• Journal of Leukocyte Biology 45:353-361 (1989) Differential Production of Tumor Necrosis Factor, Macrophage Colony Stimulating Factor, and Interleukin 1 by Human Alveolar Macrophages

  year unknowncited by this paper

• Anti-Inflammatory Activity of the Combination of Nobiletin and Docosahexaenoic Acid in Lipopolysaccharide-Stimulated RAW 264.7 Cells: A Potential Synergistic Anti-Inflammatory Effect

  2024cites this paper
• The Effect of anti-TNFα Induction Therapy on the Nutritional Status and Dietary Intake in Inflammatory Bowel Disease.

  2016cites this paper
• Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross‐sectional study

  2014cites this paper
• Deviations in Circulating TNFα Levels and TNFα Production by Mononuclear Cells in Healthy Human Populations

  2011cites this paper
• Pathophysiology of tumor-associated macrophages.

  2008cites this paper
• Effect of anti-tumor necrosis factor-therapies on body mass index in patients with psoriasis

  2008cites this paper
• Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis.

  2008influential citation
• Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth.

  2000cites this paper
• Tumor necrosis factor alpha (TNF-alpha) activates human adenoidal and cutaneous mast cells to histamine secretion.

  1997cites this paper
• Cancer immunotherapy: potential involvement of mediators

  1997cites this paper
• One Hundred Years of Cancer Immunotherapy: A Critical Appraisal

  1997cites this paper
• Tumor necrosis factor α (TNF-α) activates human adenoidal and cutaneous mast cells to histamine secretion

  1997cites this paper
• Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis.

  1996cites this paper
• Tumor necrosis factor-alpha (TNF-cx) in pleural fluids

  1995cites this paper
• Pharmacokinetics and catabolism of tumor necrosis factor-alpha in rat lungs.

  1995cites this paper
• Pharmacokinetics and catabolism of tumor necrosis factor-α in rat lungs

  1995cites this paper
• Tumor necrosis factor-alpha (TNF-alpha) in pleural fluids.

  1995cites this paper
• Relationship between virulence of Mycobacterium avium strains and induction of tumor necrosis factor alpha production in infected mice and in in vitro-cultured mouse macrophages

  1995cites this paper
• The Acute Phase Response in the Pathogenesis of Inflammatory Disease

  1995cites this paper
• Tumor necrosis factor-alpha (TNF-a) in pleural fluids

  1995cites this paper
• Modulation of luminol-dependent chemiluminescence of murine macrophages by flavone and its synthetic derivatives.

  1995cites this paper
• Pulmonary Catabolism of Interferon-γ Evaluated by Lung Perfusion of Both Normal and Smoke-Exposed Rats

  1995cites this paper
• Closed head injury triggers early production of TNF alpha and IL-6 by brain tissue.

  1994cites this paper
• Cytokine Reduction in the Treatment of Joint Conditions

  1994cites this paper
• Closed Head Injury Triggers Early Production of TNFα and IL-6 by Brain Tissue

  1994cites this paper
• Therapeutical effect of activated human macrophages on a human tumor line growing in nude mice

  1994cites this paper
• Involvement of inflammatory mediators in macrophage antitumor activity

  1993cites this paper
• Chronic cigarette smoking enhances spontaneous release of tumour necrosis factor-α from alveolar macrophages of rats

  1993cites this paper
• Effects of acute cigarette smoke exposure on macrophage kinetics and release of tumour necrosis factor α in rats

  1993cites this paper
• Activity of human peritoneal macrophages against a human tumor: role of tumor necrosis factor-alpha, PGE2 and nitrite, in vitro studies.

  1993cites this paper
• Protective effect of diclofenac sodium against endotoxic shock in anaesthetized pigs.

  1993cites this paper